GlassScriptPhysician profile
Annette E Minter
NPI 1114340767
$11,041.94
in general payments reported to CMS, 2019-2025
32 companies · $3,364 in 2025
The $3,364 reported for 2025 was more than what 98% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,507 · 2022: $2,288 · 2023: $1,857 · 2024: $2,026 · 2025: $3,364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,469 · Travel and Lodging: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,469.31 |
| Travel and Lodging | $777.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,433.63 | 2022-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $1,665.15 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Genzyme Corporation | $1,231.06 | 2021-2025 | |
| Glaxosmithkline, LLC. | $1,015.51 | 2021-2024 | Trelegy Ellipta, Nucala, Arexvy |
| Mylan Specialty L.P. | $798.26 | 2021-2024 | Yupelri |
| United Therapeutics Corporation | $486.50 | 2022-2025 | Tyvaso, Tyvaso |
| Takeda Pharmaceuticals U.S.A., INC. | $400.21 | 2021-2025 | Glassia |
| Mallinckrodt Hospital Products INC. | $371.02 | 2021-2025 | Acthar |
| Philips North America LLC | $358.46 | 2022-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Boehringer Ingelheim Pharmaceuticals, INC. | $317.03 | 2021-2025 | Ofev, Jascayd |
| Regeneron Healthcare Solutions, INC. | $282.62 | 2023-2025 | Dupixent |
| Viatris Specialty LLC | $257.48 | 2025 | Yupelri |
| Ani Pharmaceuticals, INC. | $242.18 | 2022-2025 | Purified Cortrophin Gel |
| Actelion Pharmaceuticals US, INC. | $221.21 | 2021-2025 | Uptravi, Opsumit |
| Amgen INC. | $188.85 | 2022-2024 | Tezspire |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $151.81 | 2025 | Ohtuvayre |
| Pfizer INC. | $96.00 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $75.04 | 2021-2023 | |
| Harmony Biosciences LLC | $55.99 | 2023-2024 | Wakix |
| Teva Pharmaceuticals USA, INC. | $50.22 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.67 | 2025 | |
| Jazz Pharmaceuticals INC. | $40.20 | 2025 | |
| Merck Sharp & Dohme LLC | $37.92 | 2021-2022 | |
| Baxter Healthcare | $36.34 | 2025 | Hillrom - Monarch Airway Clearance System |
| Inogen, INC. | $32.62 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Janssen Pharmaceuticals, INC | $27.85 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $25.28 | 2021 | |
| Electromed, INC. | $24.88 | 2024 | Smartvest |
| Lilly USA, LLC | $21.04 | 2025 | Zepbound, Mounjaro |
| Tactile Systems Technology INC | $20.47 | 2021 | |
| Pharming Healthcare, INC. | $14.28 | 2023 | Ruconest |
| Vanda Pharmaceuticals INC. | $14.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annette Minter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.